ISOLATED AND PURIFIED NUCLEIC ACID MOLECULE (VARIANTS), PLASMID VECTOR, ISOLATED AND PURIFIED HIGH-MOLECULAR PROTEIN (HMW) OF NONTYPICAL HAEMOPHILUS, CONJUGATE, SYNTHETIC PEPTIDE Russian patent published in 2003 - IPC

Abstract RU 2206610 C2

FIELD: genetic engineering, microbiology, peptides. SUBSTANCE: isolated and purified nucleic acid molecule encodes high-molecular protein (HMW) HMW3 or HMW4 of the strain of nontypical Haemophilus. Nucleotide sequences of DNA and amino acid sequences of protein HMW3 and HMW4 are given in the description. Plasmid vector used for transformation of Haemophilus influenzae is prepared based on pHNMW1 by insertion of DNA to it. Conjugate consists of protein HMW and antigen, hapten or polysaccharide and allows to obtain the immune response to latter. Synthetic peptide consists of 6-150 amino acids and corresponds to the protective epitope of protein HMW3 or HMW4 in nontypical Haemophilus influenzae. The protective epitope is recognized by one of monoclonal antibody AD6 and 10C5. New high-molecular proteins of nontypical Haemophilus allow to obtain the immune response to antigen, hapten or polysaccharide being used as molecule-carriers. EFFECT: valuable properties of biomolecules. 7 cl, 71 dwg, 3 tbl, 10 ex

Similar patents RU2206610C2

Title Year Author Number
GENE (VARIANTS), GENE CLASTER (VARIANTS), PROTEIN (VARIANTS), SYNTHETIC POLYPEPTIDE 1993
  • Stefen Dzh. Barenkehmp
RU2157816C2
DNA FRAGMENT ENCODING TRANSFERRIN RECEPTOR PROTEIN FRAGMENT OF STRAIN HAEMOPHILUS (VARIANTS), PLASMID VECTOR (VARIANTS), RECOMBINANT PROTEIN (VARIANTS), ISOLATED AND PURIFIED PROTEIN (VARIANTS), IMMUNOGENIC COMPOSITION AND METHOD OF ISOLATION AND PURIFICATION OF PROTEIN 1994
  • Luzmor Shina
  • Kharkness Robin
  • Shriverz Ehntoni
  • Chong Pele
  • Grej-Ouehn Skott
  • Jang Jan-Ping
  • Merdin Ehndrju
  • Klejn Majkl
RU2194757C2
PURIFIED AND ISOLATED NUCLEIC ACID MOLECULE, RECOMBINANT PLASMID, RECOMBINANT VECTOR, PURIFIED AND ISOLATED PROTEIN, PURIFIED AND ISOLATED PROTEIN D15 OR ITS PART OF EXTERNAL ENVELOPE, SYNTHETIC PEPTIDE, CHIMERIC MOLECULE, IMMUNOGENIC COMPOSITION AND ANTISERUM OR ANTIBODY 1993
  • Pele Chong
  • Vejn Tomas
  • Jan-Ping Jang
  • Shina Lusmore
  • Du Juan Charlz Sia
  • Majkl Klejn
RU2141528C1
INTRACELLULAR DOMAIN OF PROTEIN HER-2/NEU FOR PROPHYLAXIS AND TREATMENT OF MALIGNANCY 1996
  • Chiver Martin Eh.
  • Disis Mehri L.
RU2236461C2
ANNEXIN DERIVATIVES WITH ENDOGENIC SITES OF CHELATION 2000
  • Tajt Dzhonatan F.
  • Braun Dehvid S.
RU2238104C2
ANALOGUE HIN47 OF HAEMOPHILUS WITH REDUCED PROTEASE ACTIVITY 1995
  • Luzmor Shina M.
  • Jang Jan-Ping
  • Chong Pele
  • Oomen Rejmond P.
  • Kljajn Mishel' Kh.
RU2196176C2
SYNTHETIC PEPTIDE, SYNTHETIC LIPOPEPTIDE, IMMUNOGENIC CONJUGATE (VARIANTS), METHOD OF OLIGOMER PREPARING, POLYSACCHARIDE PROTECTED BY SOLID POLYETHYLENE GLYCOL MONOMETHYL ESTER 1993
  • Pele Chong
  • Ali Kandil
  • Charl'Z Saja
  • Majkl Kh.Klejn
RU2141527C1
RECOVERING VIRUS RELATED TO CANINE PARVOVIRUS-2 FROM RACOON 2010
  • Kapil Sandzhaj
RU2565538C2
CHIMERIC FLAVIVIRAL VACCINES 1998
  • Chembers Tomas Dzh.
  • Moneht Tomas P.
  • Guirakkhoo Farshad
RU2209082C2
VACCINE COMPOSITION CONTAINING TRANSFERRIN-BINDING PROTEIN AND HSF FROM GRAM-NEGATIVE BACTERIA 2003
  • Berte Fransua-Ksav'E Zhak
  • Biman Ral'F
  • Denoehl' Filipp
  • Feron Kristian
  • Gorazh Karin
  • Pulman Jan
  • Vejnants Vinsent
RU2359696C2

RU 2 206 610 C2

Authors

Behrehnkehmp Stefen Dzh.

Dates

2003-06-20Published

1997-04-01Filed